V. Hans

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis

S. Kamphuis, P. H. Hissink Muller, E. Hoppenreijs, 2020, Arthritis & Rheumatology (Hoboken, N.j.).

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study

E. Ochfeld, L. Pachman, Gabrielle A. Morgan, 2022, BMC Rheumatology.

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases

R. Fuleihan, L. Pachman, M. Curran, 2019, Pediatric Rheumatology.

Endothelial and inflammatory biomarker profile at diagnosis reflects clinical heterogeneity of juvenile dermatomyositis and is prognostic for response to treatment in two independent cohorts.

S. Kamphuis, P. H. Hissink Muller, E. Hoppenreijs, 2020, Arthritis & rheumatology.